Open AccessThe Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients
Author(s) -
Z Paul Lorenc,
Jeffrey Adelglass,
Rui L Avelar,
Leslie Baumann,
Kenneth Beer,
Joel L. Cohen,
Sue Ellen Cox,
Steven Dayan,
Jeffrey S. Dover,
Jeanine Downie,
Zoe Diana Draelos,
Mitchel P. Goldman,
John E. Gross,
John Joseph,
Joely KaufmanJanette,
Ronald L. Moy,
Mark S. Nestor,
Joel Schlessinger,
Stacy Smith,
Robert Weiß
Publication year - 2021
Publication title -
aesthetic surgery journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.528
H-Index - 58
eISSN - 1527-330X
pISSN - 1090-820X
DOI - 10.1093/asj/sjaa382
Subject(s) - medicine , adverse effect , ptosis , eyelid , surgery , multicenter study , open label study , eyebrow , forehead , dermatology , randomized controlled trial
PrabotulinumtoxinA is a 900-kDa botulinum toxin type A produced by Clostridium botulinum.